SAN DIEGO--(BUSINESS WIRE)--Sept. 20, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that human clinical trials to treat patients infected with the Hepatitis-C virus (HCV) are now...
#14: AEMD News HomelandDefenseStocks.com Homeland Security Online Conference Update: Looking Back at the Progress and Obstacles; Tracking Trends in Technology & Funding Moving Forward
POINT ROBERTS, Wash.--(BUSINESS WIRE)--Aug. 24, 2005-- www.HomelandDefenseStocks.com Announces New Participants to its Online Homeland Security Investor and Industry Conference Being Hosted...
SAN DIEGO--(BUSINESS WIRE)--Aug. 2, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that James W. Dorst has been appointed Chief Financial Officer. Mr. Dorst brings close to 20 years of...
#12: AEMD News BiodefenseStocks.com Reports on Today's Technology and Countermeasures Working to Defend against Biowarfare and Bioterrorism; Homeland Security Department Elevates Bioterrorism to Higher Level of Priority
POINT ROBERTS, Wash.--(BUSINESS WIRE)--July 20, 2005--www.BiodefenseStocks.com (BS), and www.HomelandDefenseStocks.com (HDS), investor news portals for the Biodefense and Homeland Security sectors,...
SAN DIEGO--(BUSINESS WIRE)--July 12, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced that it's Chairman and CEO, James A. Joyce, will testify today before The House Committee on Homeland...
News Article Discusses Aethlon Medical HIV/AIDS and Hepatitis-C Clinical Trials
SAN DIEGO
Aethlon Medical, Inc.
Anne Hoversten, 858-459-7800 x300 (Investor Relations)
anne@aethlonmedical.com...
Aethlon CEO Discusses Bioweapon Treatment Program
SAN DIEGO
Aethlon Medical
Anne Hoversten, 858.459.7800 x300 (Investor Relations)
anne@aethlonmedical.com
Aethlon Medical, Inc....
Aethlon Medical CEO Provides Corporate Update
SAN DIEGO
Aethlon Medical, Inc.
Anne Hoversten, 858-459-7800 x300 (Investor Relations)
anne@aethlonmedical.com
Aethlon Medical, Inc....
Aethlon Medical Sends HIV-AIDS & Hepatitis-C Treatment Technology to India
SAN DIEGO
Aethlon Medical, Inc.
Anne Hoversten, 858.459.7800 x300 (Investor Relations)
anne@aethlonmedical.com
...
Aethlon Medical Presents at National AIDS Conference
SAN DIEGO
Aethlon Medical, Inc.
Anne Hoversten, 858-459-7800 x300 (Investor Relations)
anne@aethlonmedical.com
Aethlon Medical, Inc....
Aethlon Receives Government and Industry Support for HIV and Hepatitis-C Trials in India
SAN DIEGO--(BUSINESS WIRE)--March 28, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it...
Aethlon Scientist to Present Strategy for Treating Drug Resistant HIV and Hepatitis-C
SAN DIEGO
Aethlon Medical, Inc.
James A. Joyce, 858-459-7800 x301
jj@aethlonmedical.com
or
Investor...
Aethlon Medical to Initiate Hepatitis-C Trials; Clinical Programs in India to Be Managed in Conjunction with HIV/AIDS Studies
SAN DIEGO--(BUSINESS WIRE)--Feb. 23, 2005--Aethlon Medical, Inc....
Aethlon Medical To Present Bioweapon Treatments At NYSSA Homeland Security Industry Conference
NYSSA's 2nd Annual Homeland Security Industry Conference
SAN DIEGO--(BUSINESS WIRE)--Feb....
Aethlon Medical to Initiate HIV Trials in India; Former Boston Scientific Executive to Manage Programs
SAN DIEGO--(BUSINESS WIRE)--Feb. 8, 2005--Aethlon Medical, Inc. (OTCBB:AEMD) announced...
